Mechanism of the inhibitory effects of cardiac glycosides on lipolysis.
D000577:Amides / Q000494:pharmacology; D000818:Animals; D002301:Cardiac Glycosides / Q000494:pharmacology*; D000242:Cyclic AMP / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D001728:Dicumarol / Q000494:pharmacology; D004074:Digitoxin / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D005033:Ethylmaleimide / Q000037:antagonists & inhibitors; D005978:Glutathione / Q000494:pharmacology; D005990:Glycerol / Q000378:metabolism; D006868:Hydrolysis; D066298:In Vitro Techniques; D007461:Iodoacetates / Q000494:pharmacology; D050356:Lipid Metabolism; D008053:Lipid Mobilization / Q000187:drug effects*; D008297:Male; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010042:Ouabain / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology
D000577:Amides; D002301:Cardiac Glycosides; D004140:Dinitrophenols; D007461:Iodoacetates; D013438:Sulfhydryl Compounds; D010042:Ouabain; D001728:Dicumarol; D013806:Theophylline; D000242:Cyclic AMP; D004074:Digitoxin; D005978:Glutathione; D003545:Cysteine; D005033:Ethylmaleimide; D005990:Glycerol; D009638:Norepinephrine